The U.S. Food and Drug Administration (FDA) is now required to implement nonanimal testing strategies in the evaluation of ...

Lower middle- and low-income countries are less likely to receive market authorization for drugs that were trialed within their state and approved by the FDA within 5 years of approval when compared ...

BioCytics is pleased to announce they successfully reached a regulatory milestone for de-risking clinical development plans with a productive FDA INTERACT meeting during which they discussed ...

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire ...

THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM PHILADELPHIA, PA / ACCESS Newswire / ...

On Monday, Novo Nordisk announced a discount on its popular drugs for diabetes and obesity, Ozempic and Wegovy, cutting ...

Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an ...

SAMRC warns of soaring drug use among Gauteng teens as treatment admissions rise and polysubstance use becomes increasingly ...

US FDA approves Henlius and Organon’s Poherdy, the first Perjeta biosimilar: Shanghai Tuesday, November 18, 2025, 16:00 Hrs [IST] Shanghai Henlius Biotech, Inc., a global health ...

Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into ...

Frontline Ventures leads seed round to accelerate Cellbyte’s international expansion, triple its headcount and automate more drug launch workflows Y Combinator-backed startup has scaled to six figures ...